Navigation Links
Laureate Pharma Welcomes Three New Members to Business Development Team
Date:11/2/2009

PRINCETON, N.J., Nov. 2 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and manufacture of monoclonal antibody products, fusion proteins and other recombinant protein products, today announced the addition of three new members to its Business Development team. "We're delighted to have three new team members with such extensive experience and expertise in outsourcing services and customer support joining our team," said Dan Leone, Vice President, Business Development. "We will have two team members covering eastern US/Canada and one covering western US/Canada."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Andrew Arrage joins Laureate as Director, Business Development - East. Andrew has over 15 years of experience and a proven track record in the biopharmaceutical services industry, delivering services to clients in the biotech and pharmaceutical industries.

Patricia Caplan joins Laureate as Director, Business Development - East. Patricia brings more than 20 years of experience working with clients to develop their therapeutic protein products and move them from the bench into the clinic and on to commercialization.

Bruce Frazier joins Laureate as Manager, Business Development - West. Bruce, who most recently worked in business development at a biopharmaceutical services company, has applied his experience as a quality control skilled scientist to become an accomplished business development professional dedicated to serving clients requiring biopharmaceutical testing and manufacturing services.

"Andrew, Patricia and Bruce add great depth and valuable experience to our business development team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With their strong customer service and project management skills they will play a key role in expanding Laureate's portfolio of client projects and providing critical support to our customer base."

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. For more information, contact Dan Leone, Vice President, Business Development at 609-919-3300, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Expert: For information on the listed expert, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360

SOURCE Laureate Pharma, Inc.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Elects New Board Member
3. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
4. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
5. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
6. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
7. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
8. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
9. Laureate Announces Manufacturing Agreement with Tolerx
10. Laureate Pharma to Add More Manufacturing Capacity
11. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and ... rebranding initiative announced today. The bold new look is part of a transformation ... moves into a significant growth period. , It will also expand its service offering ...
(Date:10/10/2017)... 2017 International research firm Parks Associates announced today ... the TMA 2017 Annual Meeting , October 11 in ... home security market and how smart safety and security products impact the ... Parks Associates: Smart Home Devices: ... "The residential security market has experienced ...
Breaking Biology Technology:
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):